# Intuitive Surgical, Inc. (ISRG) FY2026 Q1 Balance Sheet

- Company: Intuitive Surgical, Inc. (ISRG)
- Period: As of 2026-03-31
- Filing: Q1 FY2026 10-Q, filed 2026-04-22, accession number 0001035267-26-000032
- Page: https://plicit.ai/financials/isrg/fy2026-q1-balance-sheet
- Chart image: https://plicit.ai/charts/isrg-fy2026-q1-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-03-31. The chart shows assets, liabilities and equity at that date.

- **Assets**: 20,111,000,000 US dollars
- **Current assets**: 8,809,500,000 US dollars
- **Non-current assets**: 11,301,500,000 US dollars
- **Liabilities**: 2,513,800,000 US dollars
- **Current liabilities**: 1,911,000,000 US dollars
- **Non-current liabilities**: 602,800,000 US dollars
- **Equity**: 17,597,200,000 US dollars
- **Noncontrolling interest**: 122,700,000 US dollars. Included in consolidated equity; this amount is not added again.
- **Short-term investments**: 2,510,800,000 US dollars
- **Cash and cash equivalents**: 2,006,500,000 US dollars
- **Inventory**: 1,945,100,000 US dollars
- **Accounts receivable, net**: 1,595,600,000 US dollars
- **Prepaids and other current assets**: 751,500,000 US dollars
- **Property, plant, and equipment, net**: 5,447,900,000 US dollars
- **Long-term investments**: 3,461,900,000 US dollars
- **Intangible and other assets, net**: 1,094,700,000 US dollars
- **Deferred tax assets**: 683,800,000 US dollars
- **Goodwill**: 613,200,000 US dollars
- **Other accrued liabilities**: 647,900,000 US dollars
- **Deferred revenue**: 559,500,000 US dollars
- **Accrued compensation and employee benefits**: 370,700,000 US dollars
- **Accounts payable**: 332,900,000 US dollars
- **Other long-term liabilities**: 602,800,000 US dollars
- **Additional paid-in capital**: 11,059,900,000 US dollars
- **Retained earnings**: 6,397,700,000 US dollars
- **Accumulated other comprehensive income**: 16,500,000 US dollars
- **Common stock, 600.0 shares authorized, $0.001 par value, 354.4 shares and 355.1 shares issued and outstanding as of March 31, 2026, and December 31, 2025, respectively**: 400,000 US dollars
- **Preferred stock, 2.5 shares authorized, $0.001 par value, issuable in series; zero shares issued and outstanding as of March 31, 2026, and December 31, 2025**: 0 US dollars
- **Noncontrolling interest in joint venture**: 122,700,000 US dollars

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.